Cargando…

Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes

PURPOSE: Chronic hyperglycemia and hypoxemia are believed to be causal factors in the development of proliferative diabetic retinopathy (PDR) among individuals with type 2 diabetes. It is hypothesized that formation of new blood vessels in the retina due to prolonged hypoxia is associated with incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paine, Suman Kalyan, Basu, Analabha, Mondal, Lakshmi Kanta, Sen, Aditi, Choudhuri, Subhadip, Chowdhury, Imran Hussain, Saha, Avijit, Bhadhuri, Gautam, Mukherjee, Ankur, Bhattacharya, Basudev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Vision 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513186/ https://www.ncbi.nlm.nih.gov/pubmed/23213275

Ejemplares similares

Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
por: Choudhuri, Subhadip, et al.
Publicado: (2013)

Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales’ disease
por: Sen, Aditi, et al.
Publicado: (2011)

Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus
por: Mondal, Lakshmi Kanta, et al.
Publicado: (2018)

Growth Factors in Proliferative Diabetic Retinopathy
por: Khan, Zia Ali, et al.
Publicado: (2003)

Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population
por: Pramanik, Subhasish, et al.
Publicado: (2021)

Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous
por: Dai, Ying, et al.
Publicado: (2014)

Visual contrast sensitivity could be an early marker of diabetic retinopathy
por: Pramanik, Subhasish, et al.
Publicado: (2020)

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
por: Muhiddin, Habibah Setyawati, et al.
Publicado: (2020)

Decreased Levels of miR-126 and miR-132 in Plasma and Vitreous Humor of Non-Proliferative Diabetic Retinopathy Among Subjects with Type-2 Diabetes Mellitus
por: Pramanik, Subhasish, et al.
Publicado: (2022)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
por: Chernykh, VV, et al.
Publicado: (2015)

Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy
por: Petrovič, Mojca Globočnik, et al.
Publicado: (2008)

Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
por: Chung, Eun Jee, et al.
Publicado: (2011)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
por: Zhao, Yue, et al.
Publicado: (2018)

Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?
por: Wu, Lihteh, et al.
Publicado: (2019)

Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy
por: Chen, Hui-Jin, et al.
Publicado: (2019)

Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation
por: Al-Dwairi, Rami, et al.
Publicado: (2023)

Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy
por: Baharivand, Nader, et al.
Publicado: (2012)

Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2020)

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy
por: Van Geest, Rob J, et al.
Publicado: (2012)

Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy
por: Paine, Suman K., et al.
Publicado: (2017)

Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy
por: Gao, Xinxiao, et al.
Publicado: (2015)

Diabetic macular edema and proliferative diabetic retinopathy treated with anti-vascular endothelial growth factor under the reimbursement policy in Taiwan
por: Hsieh, Ming-Chieh, et al.
Publicado: (2022)

Diabetic Retinopathy Risk Factors: Plasma Erythropoietin as a Risk Factor for Proliferative Diabetic Retinopathy
por: Gholamhossein, Yaghoobi, et al.
Publicado: (2014)

Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
por: Perais, Jennifer, et al.
Publicado: (2023)

Pronerve Growth Factor Induces Angiogenesis via Activation of TrkA: Possible Role in Proliferative Diabetic Retinopathy
por: Elshaer, Sally L., et al.
Publicado: (2013)

Relationships among Retinal Nonperfusion, Neovascularization, and Vascular Endothelial Growth Factor Levels in Quiescent Proliferative Diabetic Retinopathy
por: Ra, Ho, et al.
Publicado: (2020)

Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
por: Shye, Michael, et al.
Publicado: (2020)

Effect of pan-retinal laser photocoagulation on intravitreal vascular endothelial growth factor concentration in proliferative diabetic retinopathy
por: Nišić, Faruk, et al.
Publicado: (2022)

Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic Retinopathy
por: Gunasekaran, Thiruvarasu, et al.
Publicado: (2022)

The Amelioration of Detrimental Biochemical Anomalies by Supplementing B, C, and E Vitamins in Subjects with Type 2 Diabetes Mellitus May Reduce the Rate of Development of Diabetic Retinopathy
por: Pramanik, Subhasish, et al.
Publicado: (2022)

Key Factors to Improve the Outcome of Retinal Reattachment Surgery in Proliferative Vitreoretinopathy and Proliferative Diabetic Retinopathy
por: Deuchler, Svenja, et al.
Publicado: (2017)

Association of Genital Chlamydia trachomatis Infection with Female Infer-tility, Study in a Tertiary Care Hospital in Eastern India
por: Ghosh, Mallika, et al.
Publicado: (2015)

Diabetic retinopathy and vascular endothelial growth factor
por: Khazaei, Majid
Publicado: (2013)

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Factors predicting final visual outcome in quiescent proliferative diabetic retinopathy
por: Kim, Jinsoo, et al.
Publicado: (2020)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

Proliferative diabetic retinopathy in acromegaly
por: Malhotra, Chintan
Publicado: (2010)

Incidence and Risk Factors for Tractional Macular Detachment after Anti-Vascular Endothelial Growth Factor Agent Pretreatment before Vitrectomy for Complicated Proliferative Diabetic Retinopathy
por: Russo, Andrea, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4sgri3h1lvrja5aimbl4pmqt28